Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression-Advantage Ketamine?

被引:4
|
作者
Mathew, Sanjay J. [1 ,2 ,7 ]
Jha, Manish K. [3 ,4 ]
Anand, Amit [5 ,6 ]
机构
[1] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX USA
[2] Michael E DeBakey VA Med Ctr, Mental Hlth Care Line, Houston, TX USA
[3] Univ Texas Southwestern Med Ctr, Dept Psychiat, Dallas, TX USA
[4] Univ Texas Southwestern Med Ctr Dallas, ODonnell Brain Inst, Dallas, TX USA
[5] Mass Gen Brigham, Dept Neurol, Boston, MA USA
[6] Harvard Med Sch, Boston, MA USA
[7] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, One Baylor Pl, Houston, TX 77024 USA
关键词
D O I
10.1001/jamapsychiatry.2023.3979
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
This Viewpoint examines key issues stemming from several recent reports of electroconvulsive therapy (ECT) vs ketamine for improving depressive symptoms in treatment-resistant depression (TRD).
引用
收藏
页码:1187 / 1188
页数:2
相关论文
共 50 条
  • [21] A systematic review of ketamine for treatment-resistant depression
    Patel, Reshmee
    Loh, Feng-Hua
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 132 - 132
  • [22] The use of subcutaneous ketamine for treatment-resistant depression
    Vargas Alves Nunes, A.
    Carrara, E.
    Odebrecht Vargas Nunes, S.
    Fernandes Jorge, I.
    Alves, E.
    Haddad, M.
    EUROPEAN PSYCHIATRY, 2019, 56 : S95 - S95
  • [23] KETAMINE FOR TREATMENT-RESISTANT DEPRESSION: A NEW ADVOCATE
    Perez-Esparza, Rodrigo
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2018, 70 (02): : 65 - 67
  • [24] Feasibility of continuation ketamine for treatment-resistant depression
    aan het Rot, Marije
    Mathew, Sanjay J.
    Collins, Katherine A.
    Perez, Andrew M.
    Murrough, James W.
    Reich, David L.
    Charney, Dennis S.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 220S - 220S
  • [25] Comparative Efficacy of Ketamine in Treatment-Resistant Depression
    Kurt, Hatice Guncu
    Altinay, Murat
    Anand, Amit
    PSYCHIATRIC ANNALS, 2020, 50 (02) : 62 - 67
  • [26] Ketamine in Late Life Treatment-Resistant Depression
    Heard, Erika
    Sohail, Yousuf
    Nagar, Anusuiya
    Glass, Oliver M.
    Hermida, Adriana P.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 25 (03): : S66 - S66
  • [27] INTRAVENOUS KETAMINE FOR TREATMENT-RESISTANT DEPRESSION IN ADOLESCENTS?
    Cullen, Kathryn R.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S284 - S284
  • [28] The role of intranasal ketamine in treatment-resistant depression
    Costa, M.
    Fraga, M.
    Moutinho, A.
    Cintra, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S492 - S492
  • [29] Magnesium in Ketamine Administration in Treatment-Resistant Depression
    Gorska, Natalia
    Cubala, Wieslaw Jerzy
    Slupski, Jakub
    Wiglusz, Mariusz Stanislaw
    Galuszko-Wegielnik, Maria
    Kawka, Mateusz
    Grzegorzewska, Agata
    PHARMACEUTICALS, 2021, 14 (05)
  • [30] Clinical Efficacy of Ketamine for Treatment-resistant Depression
    Bratsos, Sosipatros
    Saleh, Sohag N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)